Sales to assets ratio of top global pharmaceutical companies 2018

This statistic lines up some of the global top pharmaceutical companies' sales to assets ratio for the year 2018. Novo Nordisk heads the list with a sales to assets ratio of 1.05. This means that for every dollar invested in assets, the company generates 1.05 dollars of revenue in return. The average value of sales-to-assets ratio among these top companies was 0.45 in 2018.

Sales-to-assets ratio of top 20 pharmaceutical companies worldwide in 2018

Sales to assets ratio
Novo Nordisk1.05
Roche0.73
Bristol-Myers Squibb0.66
Eli Lilly0.55
GlaxoSmithKline0.54
Johnson & Johnson0.53
AbbVie0.5
Merck & Co.0.5
Biogen0.49
Celgene0.47
Novartis0.37
AstraZeneca0.35
Gilead0.33
Mylan0.33
Sanofi0.33
Pfizer0.32
Amgen0.32
Teva0.29
Endo0.27
Allergan0.14
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

September 2019

Region

Worldwide

Survey time period

2018

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.